Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Isotretinoin: cost-benefit study.

M L Lee¹, A Cooper

¹Department of Dermatology, Royal North Shore Hospital, St Leonards, NSW.

The Australasian Journal of Dermatology

|January 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intercellular Communication via Mitotic Nanotubes is Influenced by Connexin-43 Trafficking and Actin Remodeling.

bioRxiv : the preprint server for biology·2026

Same author

A phase I/IIa study of auceliciclib in patients with advanced solid tumours and in combination with temozolomide in patients with recurrent/relapsed high-grade glioma.

ESMO open·2026

Same author

Antidiuretic hormone concentrations in dogs with heart disease and relationship to serum chloride.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2025

Same author

A remote monitoring approach for coastal engineering projects.

Scientific reports·2025

Same author

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).

Journal of neuro-oncology·2024

Same author

Clinical outcomes for sexual and gender minority adolescents in a dialectical behaviour therapy programme.

Behavioural and cognitive psychotherapy·2024

Same journal

Allergic Contact Dermatitis Caused by Online-Purchased Black Henna Temporary Tattoos.

The Australasian journal of dermatology·2026

Same journal

Alpelisib for TEK- and PIK3CA-Related Venous Malformations: A Systematic Review.

The Australasian journal of dermatology·2026

Same journal

Revisiting the Role of Antibiotics in Hidradenitis Suppurativa in the Biologic Era.

The Australasian journal of dermatology·2026

Same journal

Benzalkonium Chloride in Eye Drops Causing Allergic Contact Dermatitis: A Case Series.

The Australasian journal of dermatology·2026

Same journal

The Dermatologist's Role in Early PMOS Diagnosis.

The Australasian journal of dermatology·2026

Same journal

From Curriculum Variation to Clinical Capability: Advancing Dermatology Education in Australia.

The Australasian journal of dermatology·2026

See all related articles

Isotretinoin offers a more cost-effective and highly effective solution for severe nodulocystic acne compared to traditional treatments. This acne medication provides superior results, making it a valuable therapeutic option.

Area of Science:

Dermatology
Pharmacoeconomics

Background:

Severe nodulocystic acne presents a significant therapeutic challenge.
Treatment options include isotretinoin, antibiotics, and topical therapies.
The cost of isotretinoin can be a barrier to its widespread use.

Purpose of the Study:

To compare the cost-effectiveness of isotretinoin versus conventional treatments for severe nodulocystic acne.
To evaluate the overall benefit of isotretinoin in managing severe acne.

Main Methods:

Literature review comparing treatment modalities.
Analysis of treatment duration, cost, and efficacy.

Main Results:

Isotretinoin demonstrates superior efficacy in treating severe nodulocystic acne.

Related Experiment Videos

When considering the duration of treatment, isotretinoin is more cost-effective than conventional therapies.

Significant improvements in acne severity were observed with isotretinoin.

Conclusions:

Isotretinoin is a cost-effective and highly effective treatment for severe nodulocystic acne.
The long-term benefits and efficacy outweigh the initial cost concerns.
Isotretinoin should be considered a primary treatment option for severe acne.